RHP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RHP is not a good buy right now for an impatient trader. The technical setup is bearish (downtrend + weakening momentum), near-term pattern stats also skew negative, and the latest quarter showed revenue growth but meaningful profit/EPS and margin compression. Without a proprietary buy signal or a clear bullish catalyst ahead of earnings, the risk/reward favors staying on the sidelines rather than buying immediately.
Trend/momentum: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend. MACD histogram is negative (-0.0806) and expanding to the downside, signaling weakening momentum. RSI(6)=45.1 is neutral but slightly soft—no oversold bounce signal yet. Levels: Current price 94.31 is below the pivot (95.313), keeping bias bearish. Nearest support is S1=93.186 (then S2=91.871). If support fails, downside can accelerate. Resistance sits at R1=97.441 and R2=98.756; bulls would need a reclaim of the pivot and follow-through above ~97.44 to improve the setup. Quant pattern read: Similar-pattern projection shows ~60% odds of -6.21% over the next week and -7.02% over the next month—consistent with the bearish trend.
Intellectia Proprietary Trading Signals
Analyst support from Barclays (Overweight, PT $
and Truist (Buy, PT $
provides valuation/flow tailwind if fundamentals stabilize.
Upcoming earnings (2026-02-23 after hours) could reset expectations if margins rebound and guidance is solid.
If price holds 93.2 support and reclaims the 95.3 pivot, a technical relief rally toward ~97.4–98.8 becomes more likely.
Technical downtrend is intact (bearish MA stack + negative MACD expansion), increasing odds of another leg down if support breaks.
Q3 2025 profitability deterioration: Net income (-40.9% YoY), EPS (-43.5% YoY), and gross margin down meaningfully—weak operating leverage despite revenue growth.
Morgan Stanley’s PT cut to $88 (Equal Weight) sits below the current price, reinforcing downside risk if the market focuses on muted lodging/leisure fundamentals and rates pressure services demand.
Latest reported quarter: 2025/Q3. Revenue rose to $592.46M (+7.73% YoY), but profitability weakened sharply: net income fell to $34.89M (-40.88% YoY), EPS to $0.52 (-43.48% YoY), and gross margin dropped to 17.09 (down -19.31% YoY). The key takeaway is growth in the top line but notable margin/EPS compression, which typically limits near-term upside until operating trends improve.
Recent trend is mixed. Bullish: Truist maintained Buy and nudged PT up to $121 (2025-12-04); Barclays initiated Overweight with $110 PT (2026-01-06). Bearish/tempering: Morgan Stanley lowered PT to $88 and stayed Equal Weight (2026-01-16), citing muted fundamentals and macro/rates effects. Wall Street pro view (pros/cons): Pros—multiple bullish targets above spot suggest upside if fundamentals re-accelerate; company seen as having a definable strategy/solid balance sheet (per Barclays). Cons—recent PT cut to below current price and commentary about muted sector fundamentals; the market is currently rewarding clearer acceleration/margin expansion, which RHP’s latest quarter did not show. Influential/politician trading: No recent congress trading data available in the last 90 days. Hedge funds and insiders are reported as neutral with no significant recent trend.
